Immunotherapy drugs have led to long-lasting remissions for some cancer patients with advanced disease. They also come with a new and diverse array of side effects.
by Kate Yandell
An opinion piece discusses how the stigma surrounding opioids affects cancer patients, and a study provides data on treating melanoma patients with brain metastases.
The National Cancer Institute’s Todd Horowitz discusses cancer-related cognitive impairment.
Two studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed.
Studies explore what type of cervical cancer screening is most effective and whether patients with autoimmune diseases can take immunotherapy.
A handheld device may accurately detect heart dysfunction in childhood cancer survivors treated with chemotherapy.
The U.S. Food and Drug Administration expands use of the immunotherapy Keytruda (pembrolizumab) to two new cancer types.
How far has immunotherapy advanced in that time?
Editor-in-Chief William G. Nelson Discusses Cancer Today
donate to the AACR
The AACR Cancer Progress Report 2017, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.